DNAprint Genomics (DNAG)

[frogdreaming]

It's a pretty safe bet that the deal has gone down. The circumstantial evidence all points to a completion of the arrangement.

Biofrontera has ammended their list of Directors to include the DNAP additions.

There has been a huge increase in the issued shares since the announcement of the deal and yet the pps has not dropped proportionally. There is evidently an entity buying up the extra shares just as one would expect if Dutchess was acumulating their slice.

If the deal had failed, the market would have already started to react and the pps would have dropped on increasing volume in the last few days.

I don't expect any bloodbath next week.

regards,
frog